Financhill
Back

Plus Therapeutics Stock Predictions

Sell
28

PSTV
Plus Therapeutics

Last Price:
0.47
Seasonality Move:
-6.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Plus Therapeutics Stock Forecast

  • Is Plus Therapeutics Stock Undervalued?
    The current Plus Therapeutics [PSTV] share price is $0.47. The Score for PSTV is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • PSTV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Plus Therapeutics Stock Go Up Next Year?

Data Unavailable

Plus Therapeutics Stock Rating

Data Unavailable

Plus Therapeutics Stock Price History

Is PSTV stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight selling pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
plustherapeutics.com

52-Week Data

52-Week High:
2.16
52-Week Low:
0.39

Prediction Charts

Market Cap:
10.49M
Price in USD:
0.47
Volume:
289.58K
Beta:
1.31

Technical Analysis

SMA50:
0.61
SMA100:
0.58
SMA200:
0.77
52-Wk Change:
-74.56%

Stock Predictions

  • Is Plus Therapeutics stock public?
    Yes, Plus Therapeutics is a publicly traded company.
  • What is the Plus Therapeutics stock quote today?
    The Plus Therapeutics stock price isĀ 0.47 USD today.
  • How to buy Plus Therapeutics stock online?
    You can buy Plus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-15 0.60 0.62 0.69 0.58
Sep-16 0.60 0.60 0.61 0.58
Sep-19 0.58 0.56 0.60 0.54
Sep-20 0.54 0.53 0.56 0.51
Sep-21 0.54 0.49 0.54 0.47
Sep-22 0.52 0.49 0.53 0.46
Sep-23 0.46 0.50 0.50 0.43
Sep-26 0.48 0.49 0.51 0.44
Sep-27 0.48 0.47 0.49 0.46
Sep-28 0.46 0.50 0.53 0.45
Sep-29 0.47 0.48 0.49 0.46
Sep-30 0.47 0.45 0.48 0.44
Oct-3 0.45 0.44 0.47 0.44
Oct-4 0.45 0.47 0.49 0.45

Plus Therapeutics Earnings

Data Unavailable

Plus Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.06 per share.

* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.